RIO DE JANEIRO, BRAZIL - The Oswaldo Cruz Foundation (Fiocruz) on Thursday, May 20, suspended production of the Oxford/AstraZeneca vaccine due to a raw material shortage. Fiocruz is expecting the arrival from China of a shipment of the active pharmaceutical ingredient (API) on Saturday, May 22, to restart production.
On Friday, May 14, the Butantan Institute in São Paulo had also completely suspended the production of the CoronaVac vaccine due to a raw material shortage.
Assuming the shipment of API arrives as expected, Fiocruz production will restart on Tuesday, May 25.
AstraZeneca and CoronaVac are the only two . . .